Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of structurally diverse FSP1 inhibitors that sensitize cancer cells to ferroptosis
Joseph M. Hendricks, Cody E. Doubravsky, Eddie Wehri, et al.
Cell chemical biology (2023) Vol. 30, Iss. 9, pp. 1090-1103.e7
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

The cell biology of ferroptosis
Scott J. Dixon, James A. Olzmann
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 6, pp. 424-442
Closed Access | Times Cited: 294
Targeting ferroptosis opens new avenues for the development of novel therapeutics
Shumin Sun, Jie Shen, Jianwei Jiang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 232
The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 171
FSP1: a key regulator of ferroptosis
Wentao Li, Longteng Liang, Siyi Liu, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 9, pp. 753-764
Open Access | Times Cited: 106
Ferroptosis in health and disease
Carsten Berndt, Hamed Alborzinia, Vera Skafar Amen, et al.
Redox Biology (2024) Vol. 75, pp. 103211-103211
Open Access | Times Cited: 69
Oxidative cell death in cancer: mechanisms and therapeutic opportunities
Xiaoqin An, Wenfeng Yu, Jinbao Liu, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 8
Open Access | Times Cited: 64
The mechanism of ferroptosis and its related diseases
Shijian Feng, Dan Tang, Yichang Wang, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 62
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 51
Sensitization of cancer cells to ferroptosis coincident with cell cycle arrest
Jason Rodencal, Nathan G. Kim, Andrew He, et al.
Cell chemical biology (2023) Vol. 31, Iss. 2, pp. 234-248.e13
Closed Access | Times Cited: 43
Exploiting ferroptosis vulnerabilities in cancer
Toshitaka Nakamura, Marcus Conrad
Nature Cell Biology (2024) Vol. 26, Iss. 9, pp. 1407-1419
Closed Access | Times Cited: 27
Immunogenicity of ferroptosis in cancer: a matter of context?
Elena Catanzaro, Robin Demuynck, Faye Naessens, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 407-416
Closed Access | Times Cited: 18
A Multifunctional Covalent Organic Framework Nanozyme for Promoting Ferroptotic Radiotherapy against Esophageal Cancer
Lele Zhou, Qun Guan, Wei Zhou, et al.
ACS Nano (2023) Vol. 17, Iss. 20, pp. 20445-20461
Closed Access | Times Cited: 35
Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation
Toshitaka Nakamura, Eikan Mishima, Naoya Yamada, et al.
Nature Structural & Molecular Biology (2023) Vol. 30, Iss. 11, pp. 1806-1815
Open Access | Times Cited: 33
Disorders of Endogenous and Exogenous Antioxidants in Neurological Diseases
Izabela Korczowska-Łącka, Bartosz Słowikowski, Thomas Piekut, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1811-1811
Open Access | Times Cited: 30
Unleashing Ferroptosis in Human Cancers: Targeting Ferroptosis Suppressor Protein 1 for Overcoming Therapy Resistance
Jaewang Lee, Jong‐Lyel Roh
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1218-1218
Open Access | Times Cited: 23
FSP1-mediated ferroptosis in cancer: from mechanisms to therapeutic applications
Ran Gao, Jinge Wang, Jingjing Huang, et al.
APOPTOSIS (2024) Vol. 29, Iss. 7-8, pp. 1019-1037
Closed Access | Times Cited: 15
Ferroptosis in Cancer Therapy: Mechanisms, Small Molecule Inducers, and Novel Approaches
YiLin Luo, Xin Yue Bai, L.J. Zhang, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2485-2529
Open Access | Times Cited: 9
Ferroptosis: mechanisms and therapeutic targets
Qian Zhou, Yu Meng, Jiayuan Le, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 9
Epithelial-mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis
Wenzheng Guo, Zhibing Duan, Jingjing Wu, et al.
Seminars in Cancer Biology (2025)
Closed Access | Times Cited: 1
Lipid Quality Control and Ferroptosis: From Concept to Mechanism
Zhipeng Li, Mike Lange, Scott J. Dixon, et al.
Annual Review of Biochemistry (2023) Vol. 93, Iss. 1, pp. 499-528
Closed Access | Times Cited: 19
Ferroptosis inducers: A new frontier in cancer therapy
Wenjing Ma, Naiyuan Hu, Wenqian Xu, et al.
Bioorganic Chemistry (2024) Vol. 146, pp. 107331-107331
Closed Access | Times Cited: 8
A guide to ferroptosis in cancer
Fatma Isil Yapici, Christina M. Bebber, Silvia von Karstedt
Molecular Oncology (2024) Vol. 18, Iss. 6, pp. 1378-1396
Open Access | Times Cited: 7
Unresolved questions regarding cellular cysteine sources and their possible relationships to ferroptosis
Elias S J Arnér, Edward E. Schmidt
Advances in cancer research (2024), pp. 1-44
Closed Access | Times Cited: 7
Understanding Coenzyme Q
Ying Wang, Noah Lilienfeldt, Siegfried Hekimi
Physiological Reviews (2024) Vol. 104, Iss. 4, pp. 1533-1610
Open Access | Times Cited: 7
Unlocking ferroptosis in prostate cancer — the road to novel therapies and imaging markers
Pham Hong Anh Cao, Abishai Dominic, Fabiola Ester Lujan, et al.
Nature Reviews Urology (2024) Vol. 21, Iss. 10, pp. 615-637
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top